BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Horizon Pharma plc 

Connaught House, 1st Floor
1 Burlington Road
Dublin 4      Ireland
Phone: +353-1-72-2100 Fax:


SEARCH JOBS










 Company News
Horizon Pharma (HZNP) Announces Pricing Of Public Offering Of Ordinary Shares 4/17/2015 11:01:22 AM
Horizon Pharma (HZNP) Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering PENNSAID2% 4/17/2015 10:53:15 AM
Horizon Pharma (HZNP) Announces Proposed Public Offering Of Ordinary Shares 4/14/2015 12:48:45 PM
Horizon Pharma (HZNP) Receives FDA Fast Track Designation For ACTIMMUNE In The Treatment Of Friedreich's Ataxia 4/10/2015 11:51:55 AM
Horizon Pharma (HZNP) Names Geoffrey M. Curtis Group Vice President, Corporate Communications 4/9/2015 10:03:36 AM
Horizon Pharma (HZNP) Acquires Hyperion Therapeutics (HPTX) and Its Revenue-Boosting Pipeline for $1.1B 3/30/2015 7:40:34 AM
Horizon Pharma (HZNP) To Acquire Hyperion Therapeutics (HPTX) For $46.00 Per Share Or $1.1 Billion In Cash 3/30/2015 6:44:24 AM
Horizon Pharma plc.  (HZNP) And The Chicago Innovation Awards To Ring The Nasdaq Stock Market Closing Bell 3/23/2015 1:04:40 PM
Horizon Pharma plc.  (HZNP) Closes Offering Of $400 Million Of 2.50% Exchangeable Senior Notes, Including Exercise In Full Of Option To Purchase Additional Notes 3/17/2015 1:01:09 PM
Horizon Pharma plc.  (HZNP) Prices Offering Of $350 Million Of 2.50% Exchangeable Senior Notes 3/9/2015 11:54:54 AM
12345678910...